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Abstract
Background: Proliferative verrucous leukoplakia (PVL) is an oral potentially malignant disorder, characterized by
multifocal expression, progressive clinical evolution, and a high rate of malignant transformation. Evidence-based
information regarding optimal PVL management is lacking, due to the paucity of data. The present report describes
a case of PVL associated with HPV-16 infection and epithelial dysplasia treated by diode laser surgery, and the
outcome of disease clinical remission over a 2-year follow-up period.
Case report: A 61-year-old Caucasian male with oral verrucous hyperkeratosis presented for diagnosis. The lesions
were localized on the maxillary gingiva and palatal alveolar ridge. Multiple biopsy specimens have been taken by
mapping the keratotic lesion area. Microscopic examination was compatible with a diagnosis of PVL with focal mild
dysplasia, localized in the right maxillary gingiva. Polymerase chain reaction (PCR) was done for human
papillomavirus (HPV) detection which revealed presence of HPV DNA, and the genotype revealed HPV 16 in the
sample. The PVL in the right gingival area was treated on an outpatient basis by excision with a diode laser. This
approach resulted in good clinical response and decreased morbidity over a 2-year follow-up period.
Conclusions: This case illustrates the benefit of a conservative approach by diode laser treatment than wide
surgical excision for management of the PVL lesions associated with mild dysplasia and HPV-16 infection.
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Background
Proliferative verrucous leukoplakia (PVL) is a distinct
variant of the oral leukoplakia, which is classified as an
oral potentially malignant disorder (OPMD) and typified
by a high transformation rate and morbidity [1, 2].
PVL was first described in 1985 by Hansen et al. as a
long-term progressive condition characterized by multi-
focal hyperkeratosis with confluent, exophytic, and pro-
liferative manifestations [3].
The etiology of the PVL remains unknown. Tobacco
use is not a common factor associated with PVL, being
present in about a third of the cases [4, 5]. The
relationship between the onset of PVL and alcohol con-
sumption has not been established [6–9].
As regard the clinical management, there is lack of
high-quality data to support the routine surgical excision
of the non-invasive phase of PVL (Hansen’s grades 3–5) in
an attempt to prevent future malignant transformation [2].
The role of the human papillomavirus (HPV) infection
in the pathogenesis of the PVL is never been defined,
and current evidences are contradictory [2, 9–11].
However, it should be considered that the infection of
PVL lesions with high-risk HPV subtypes—such as HPV
16 and 18—could increase the transforming potential as
a result of the expression of E6 and E7 viral oncopro-
teins, which functionally inactivate two human tumor
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suppressor proteins, p53 and pRb, respectively [12, 13].
Below, we present a case of PVL with HPV-16 infection
managed by diode laser ablation 2 years and followed up
after treatment.
Case presentation
In January 2015, a 61-year-old Caucasian male was re-
ferred to our Oral Pathology and Medicine Unit by his
own dentist for white oral lesions, since it was initially
thought to be a fungal infection and he had received
treatment based on topical antifungals, without a signifi-
cant clinical improvement.
Past medical history included appendectomy, chole-
cystectomy, and tonsillectomy. He had never smoked or
used drugs recreationally and did not drink alcohol. At
the time of the first visit, he was not taking any medica-
tion. No symptoms were referred by the patient, but he
had noted a progressive increase of the lesion size in re-
cent months. Clinical examination showed a thickened
hyperkeratosis, which was confluent in widely exophytic
papillary plaques. These lesions appeared homoge-
neously whitish-gray with verrucous surface and local-
ized on the maxillary gingiva and palatal and alveolar
ridge mucosa (Fig. 1). Incisional biopsies were per-
formed, and multiple samples of tissue from the lesions
were taken, using a 3-mm punch biopsy.
Pathological findings
The histopathological analysis revealed exophytic, hyper-
keratotic lesions with prominent verruciform or papillary
surface and acanthosis forming droplet-shaped epithelial
projections into the lamina propria (Fig. 2). A sample was
described as a hyperkeratosis with finding areas of verru-
cous hyperplasia. Other two gingival samples showed a
hyperkeratosis with focal mild degree dysplasia (Fig. 3).
Some areas showed intraepithelial alteration compatible
with human papillomavirus infection. One portion of the
gingival biopsy specimen, previously frozen, was used for
DNA (deoxyribonucleic acid) extraction. Human papillo-
mavirus DNA presence was confirmed with polymerase
chain reaction (PCR) amplifications, and the viral typing,
by direct sequencing of DNA common genomic region
L1, displayed positive result for research of HPV subtype.
Before surgical procedure, a complete blood cell count
was performed to exclude coagulation disorders, along
with viral profile. The excision of the lesion has been per-
formed, under local anesthesia, using a diode laser
(wavelength 808 nm) set at 1.5 W, the optical fiber,
300 μm, in a pulsated-wave emission mode to reduce the
layer carbonization of the tissues (Fig. 4). The size of the
lesion was 1.25 × 3.0 cm, and the laser settings were flu-
ence 16 J/cm2, pulse length 20 ms, and spot diameter of
2 mm. No postoperative complications, as well as no
swelling and/or pain reported by the patient, have been
observed. A periodic follow-up every 6 months has been
scheduled. At the last oral examination, 2 years after sur-
gery, we found no signs of loss of alveolar process in cor-
respondence of the surgical ablation site, whereas a mild
hyperkeratosis of the maxillary vestibular gingiva was clin-
ically objectified (Fig. 5). The microscopic examination
performed on a tissue specimen taken in the same area of
Fig. 1 Verrucous hyperkeratosis in the right maxillary gingiva at the
first clinical examination
Fig. 2 Severe verrucous hyperkeratosis with elongation of dermic
ridges and mild chronic inflammatory infiltrate in the underlying
stroma (H&E, 100 o.m)
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the laser treatment showed no signs of epithelial dysplasia
(Fig. 6).
Conclusions
Currently, no specific treatment modality has proven to be
effective in the management of the PVL, either to slow
down its progression toward malignant transformation and
limit the high frequency of recurrence [2, 14]. Therefore,
the patients with PVL need multiple biopsies over time to
identify the histologic status of this progressive disorder [3].
The conventional treatment of PVL is surgical exci-
sion, although complete removal of the lesions may be
challenging because of the multifocal manifestation of
the oral lesions [14]. This approach can lead to signifi-
cant morbidity and compromised quality of life. How-
ever, the presence of HPV-16 infection associated with
epithelial dysplasia can justify—as the present case—the
wide surgical excision of the affected site, trying to
minimize the operational invasiveness. A systematic
literature review found that there is a potentially causal
association between oral leukoplakia infected by HPV 16
and epithelial dysplasia, as well as with oral squamous
cell carcinoma (OSCC) [15]. It is important to consider
that the biopsy sampling represents a powerful tool to
demonstrate the relationship between HPV infection
and oral dysplasia, since it has been shown that HPV
DNA in exfoliated cells is not associated with HPV
DNA detection in OSCCs [13, 15]. Furthermore, the
multifocal development of the PVL lesions draws atten-
tion to the risk of field cancerization model, making the
field mapping mandatory during the course of multiple
biopsies sampling. The oncogenic potential of the HPV
infection is attributable to its ability to insert specific
DNA fragments of the early genes E5, E6, and E7 into
the host cell genome. As a result of this integration,
some key functions of tumor suppressor factors such as
p21, p53, and pRb pathways are inhibited, leading to
Fig. 3 Magnification of the Fig. 2: proliferative verrucous leukoplakia,
basal layer with mitosis and low grade cytological atypia (H&E, 400 o.m)
Fig. 4 Surgical excision of the verrucous leukoplakia by a diode
laser. Note the complete absence of hemorrhage
Fig. 5 At 2 years of follow-up, the clinical examination showed a mild
hyperkeratosis on the ipsilateral gingiva treated by a diode laser
Fig. 6 Sample of tissue taken in the same area as the previous laser
treatment: proliferative verrucous leukoplakia, basal layer without
evidence of mitosis and cytological atypia (H&E, 400 o.m)
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defects in apoptosis, DNA repair mechanisms, cell cycle
regulation, and finally to [16]. In the current case, the
choice of the laser excision of the whole dysplastic lesion
was made in the attempt of achieving a viral contamin-
ation abatement through a minimally invasive proced-
ure. As a matter of fact, the lateral expansion of the viral
particles into the scar tissue maintains the infectivity in
the tissue repair and permits the viral replication cycle,
whereas the lack of activity of late proteins in the cells
holds the primary infection in the basal layer, permitting
recurrent infections [17]. It seems likely that the use of
the laser surgery can induce—through the photo thermal
effect—denaturation of the virus proteins in infected
cells, extending the heat achieved by the high tempera-
tures to areas beyond the lesion margins, thereby redu-
cing the amount of infected tissue [18]. These findings
have been confirmed by the lower viral load values in
samples obtained at 20 days after surgery when using
the diode laser [19]. Additionally, as regard the
decision-making process in the surgical treatment of
PVL with low grade dysplasia, it should be considered
that no clinical characteristics—clinical appearance, le-
sion color, lesion surface—showed any significant correl-
ation with malignant transformation to detect oral
cancer in the early stage [20]. As previously reported,
the tongue and gingiva are the most common transform-
ation sites in PVL lesions, and it has been emphasized,
in particular, the importance of the gingival surveillance,
as described in the present case [6, 21]. Taking into ac-
count the high recurrence rate in the clinical course of
PVL, the abovementioned surgical management was pri-
marily directed to keeping under control the viral load
of HPV infection and the potential progression of epi-
thelial dysplasia to malignant transformation. Finally,
particular vigilance should be turned to the periodontal
status of PVL patients, since it is more likely that OSCCs
in PVL areas are located in the masticatory mucosa, par-
ticularly in the gingiva. Moreover, periodontal disease
has been associated with a small, but statistically signifi-
cant, increase in overall oral cancer risk, which persisted
among non-smokers [6, 22–25].
Although recurrence and progression are very com-
mon in the PVL lesions, whether the microscopic
evaluation of the tissue sample confirms the HPV in-
fection associated with mild dysplasia, the laser exci-
sion can be considered as surgical option. Biopsy
mapping and complete laser excision of PVL tissue
associated with epithelial dysplasia appear to be reli-
able, reproducible procedures associated with low
complications and morbidity rates in terms of pre-
venting malignant transformation. Strict follow-up is
recommended for patients with PVL associated with
HPV-16 infection and low grade dysplasia to detect
oral cancer at an early stage.
Nonsurgical therapeutic approaches for PVL have been
considered such as external beam radiation therapy,
cryotherapy, topical vitamin, and topical chemotherapy,
but with little success. Cryosurgery, photodynamic ther-
apy, and antiviral methisoprinol therapy have also been
suggested with significant benefit. In the future,
anti-HPV, anti-TGF, and pro-apoptotic management
strategies may be assessed [2, 4, 14].
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